BriaCell Therapeutics (BCTXW) Competitors $0.28 -0.01 (-3.45%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends BCTXW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ARAV, ACABW, ACABU, and BFRIWShould you be buying BriaCell Therapeutics stock or one of its competitors? The main competitors of BriaCell Therapeutics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry. BriaCell Therapeutics vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Alvotech Aravive Atlantic Coastal Acquisition Corp. II Atlantic Coastal Acquisition Corp. II Biofrontera BriaCell Therapeutics (NASDAQ:BCTXW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, valuation, earnings, profitability, institutional ownership, media sentiment, risk and dividends. Does the media prefer BCTXW or ATNFW? In the previous week, BriaCell Therapeutics had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for BriaCell Therapeutics and 1 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.87 beat BriaCell Therapeutics' score of 1.43 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment BriaCell Therapeutics Positive 180 Life Sciences Very Positive Is BCTXW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets BriaCell TherapeuticsN/A N/A N/A 180 Life Sciences N/A N/A N/A Does the MarketBeat Community believe in BCTXW or ATNFW? BriaCell Therapeutics and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformBriaCell TherapeuticsN/AN/A180 Life SciencesN/AN/A Which has preferable valuation & earnings, BCTXW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBriaCell TherapeuticsN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A SummaryBriaCell Therapeutics and 180 Life Sciences tied by winning 1 of the 2 factors compared between the two stocks. Ad WealthPressThe only candlestick pattern worth a darnIt’s widely known that 80% of daily market action is driven by Wall Street algorithms… Now, most people think of the algorithms are “bad” When in reality, they are neither good nor bad… They are simply programmed to buy and sell certain stocks over and over again… But here is the thing… They are predictable… They typically buy the same stocks at the same levels over and over again…Follow this link here and enter your email address to sign up… Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCTXW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BCTXW vs. The Competition Export to ExcelMetricBriaCell TherapeuticsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$150.91M$5.12B$8.72BDividend YieldN/A3.64%5.18%4.07%P/E RatioN/A187.6772.8114.16Price / SalesN/A16,673.191,250.2081.71Price / CashN/A12.4640.7036.03Price / BookN/A7.886.455.94Net IncomeN/A-$20.05M$119.73M$225.73M7 Day Performance-6.70%7.83%-5.13%-1.34%1 Month Performance-7.01%11.90%-2.71%1.15%1 Year Performance-83.04%31.41%31.08%24.02% BriaCell Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BCTXWBriaCell TherapeuticsN/A$0.28-3.4%N/A-81.4%$0.00N/A0.008Short Interest ↓Positive NewsATNFW180 Life SciencesN/A$0.01flatN/A-32.5%$0.00N/A0.007Positive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.04flatN/AN/A$0.00N/A0.002Gap UpAIMDWAinosN/A$0.03flatN/A-94.2%$0.00$40,633.000.0040Positive NewsALVOWAlvotechN/A$3.11+0.3%N/A+98.1%$0.00$306.77M0.004Short Interest ↓Positive NewsGap UpHigh Trading VolumeALVOAlvotech2.3606 of 5 stars$11.73-2.8%$18.00+53.5%+29.9%$0.00$93.38M-6.341,026News CoverageARAVAravive0.6902 of 5 stars$0.04flatN/AN/A$0.00$9.14M-0.0420High Trading VolumeACABWAtlantic Coastal Acquisition Corp. IIN/A$0.06flatN/A-10.3%$0.00N/A0.004Positive NewsHigh Trading VolumeACABUAtlantic Coastal Acquisition Corp. IIN/A$8.05-26.8%N/AN/A$0.00N/A0.004Gap DownBFRIWBiofronteraN/A$0.07-22.2%N/A+279.9%$0.00$35.24M0.0070Positive NewsGap Up Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Alvotech Competitors Alvotech Competitors Aravive Competitors Atlantic Coastal Acquisition Corp. II Competitors Atlantic Coastal Acquisition Corp. II Competitors Biofrontera Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BCTXW) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BCTXW Stock Alerts